✦ LIBER ✦
Commentary on Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer: Morris MJ, Huang D, Kelly WK, Slovin SF, Stephenson RD, Eicher C, Delacruz A, Curley T, Schwartz LH, Scher HI, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Weill Medical College of Cornell University, New York, NY
✍ Scribed by Daniel W. Lin
- Book ID
- 116956651
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 75 KB
- Volume
- 27
- Category
- Article
- ISSN
- 1078-1439
No coin nor oath required. For personal study only.